SmartTRAK's Final 2017 US Surgical Matrices Market Financial Results

The US Surgical Matrices Market advanced again in Q417, reaching sales of $338.2MM, up +6.8% YoY, fueled by double-digit growth in allograft breast matrices and biosynthetics hernia matrices.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Surgical Matrices Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Surgical Matrices Market Recap are:

• Q417 US Surgical Matrices Overview
• US Breast Matrices: Allografts Dominate
• US Hernia Market: Medtronic's Growth Leads the Pack in Synthetics
• Notable Events in the Q417 Surgical Matrices Market

 The US Surgical Matrices market saw an increase in both Breast and Hernia segments, with far more growth in the Breast Matrices market, coming in at ...

Read the entire US Surgical Matrices Market Recap  including new, data and analysis*

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.